Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities

被引:11
|
作者
Song, Joo Y. [1 ]
Dirnhofer, Stefan [2 ]
Piris, Miguel A. [3 ]
Quintanilla-Martinez, Leticia [4 ,5 ,6 ]
Pileri, Stefano [7 ]
Campo, Elias [8 ]
机构
[1] City Hope Natl Med Ctr, Dept Pathol, 1500 E Duarte Rd, Duarte, CA 91010 USA
[2] Univ Basel, Univ Hosp Basel, Inst Med Genet & Pathol, Basel, Switzerland
[3] Fdn Jimenez Diaz, Serv Anat Patol, CIBERONC, Madrid, Spain
[4] Eberhard Karls Univ Tubingen, Inst Pathol & Neuropathol, Tubingen, Germany
[5] Univ Hosp Tubingen, Comprehens Canc Ctr, Tubingen, Germany
[6] Image Guided & Funct Instructed Tumor Therapy, Cluster Excellence iFIT, Tubingen, Germany
[7] European Inst Oncol IRCCS, Div Hematopathol, Milan, Italy
[8] Univ Barcelona, Hosp Clin Barcelona, Inst Biomed Res August Pi I Sunyer IDIBAPS, Hematopathol Unit, Barcelona, Spain
关键词
Diffuse large B-cell lymphoma; Update; Classification; Molecular; Genomics; CENTRAL-NERVOUS-SYSTEM; PREVIOUSLY UNTREATED PATIENTS; EFFUSION-BASED LYMPHOMA; EXPRESSION PREDICTS; CD79B MUTATIONS; GENE-EXPRESSION; MYD88; L265P; R-CHOP; CLASSIFICATION; MYC;
D O I
10.1007/s00428-022-03466-6
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Diffuse large B-cell lymphoma (DLBCL) is an aggressive and heterogenous group of diseases and the most common subtype of non-Hodgkin lymphoma. In the past decade, there has been an explosion in molecular profiling that has helped to identify subgroups and shared oncogenic driving mechanisms. Since the 2017 World Health Organization (WHO) classification, additional studies investigating these genomic abnormalities and phenotypic findings have been reported. Here we review these findings in DLBCL and address the proposed changes by the 2022 International Consensus Classification.
引用
收藏
页码:179 / 192
页数:14
相关论文
共 50 条
  • [1] Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities
    Joo Y. Song
    Stefan Dirnhofer
    Miguel A. Piris
    Leticia Quintanilla-Martínez
    Stefano Pileri
    Elias Campo
    Virchows Archiv, 2023, 482 : 179 - 192
  • [2] The altered metabolic pathways of diffuse large B-cell lymphoma not otherwise specified
    Rodrigues-Fernandes, Carla Isabelly
    Martins-Chaves, Roberta Rayra
    Vitorio, Jessica Gardone
    Duarte-Andrade, Filipe Fideles
    Pereira, Thais dos Santos Fontes
    Soares, Ciro Dantas
    Moreira, Victor Rezende
    Lebron, Yuri Abner Rocha
    Santos, Lucilaine Valeria de Souza
    Lange, Lisete Celina
    Canuto, Gisele Andre Baptista
    Gomes, Carolina Cavalieri
    de Macedo, Adriana Nori
    Pontes, Helder Antonio Rebelo
    Burbano, Rommel Mario Rodriguez
    Martins, Manoela Domingues
    Pires, Fabio Ramoa
    Mesquita, Ricardo Alves
    Gomez, Ricardo Santiago
    Santos-Silva, Alan Roger
    Lopes, Marcio Ajudarte
    Vargas, Pablo Agustin
    Fonseca, Felipe Paiva
    LEUKEMIA & LYMPHOMA, 2023, 64 (11) : 1771 - 1781
  • [3] Diffuse large B-cell lymphomas: Variants and entities
    Anagnostopoulos, I
    Stein, H
    PATHOLOGE, 2000, 21 (02): : 178 - 189
  • [4] Comparison of the Lymph2Cx Assay and Hans Algorithm in Determining the Cell-of-Origin of Diffuse Large B-Cell Lymphomas, Not Otherwise Specified
    Cho, Inju
    Yoon, Nara
    Hyeon, Jiyeon
    Sim, Jongmin
    Yoo, Hae Yong
    Kim, Seok Jin
    Kim, Won Seog
    Ko, Young Hyeh
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2020, 28 (10) : 731 - 740
  • [5] Diffuse Large B-Cell Lymphomas and Burkitt Lymphoma
    de Leval, Laurence
    Hasserjian, Robert Paul
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2009, 23 (04) : 791 - +
  • [6] Diffuse Aggressive B-cell Lymphomas
    Said, Jonathan
    ADVANCES IN ANATOMIC PATHOLOGY, 2009, 16 (04) : 216 - 235
  • [7] Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified, in the Oral Cavity
    dos Santos Costa, Sara Ferreira
    Barbosa Silva, Andre Myller
    Amaral-Silva, Gleyson Kleber
    Rebelo Pontes, Helder Antonio
    Correa Pontes, Flavia Sirotheau
    Fonseca, Felipe Paiva
    de Almeida, Oslei Paes
    JOURNAL OF CRANIOFACIAL SURGERY, 2019, 30 (03) : E259 - E262
  • [8] Proteomic Profiling of Diffuse Large B-Cell Lymphomas
    Kwiecinska, Anna
    Porwit, Anna
    Souchelnytskyi, Nazariy
    Kaufeldt, Ann
    Larsson, Catharina
    Bajalica-Lagercrantz, Svetlana
    Souchelnytskyi, Serhiy
    PATHOBIOLOGY, 2018, 85 (04) : 211 - 219
  • [9] Predictive and Prognostic Molecular Factors in Diffuse Large B-Cell Lymphomas
    Pileri, Stefano A.
    Tripodo, Claudio
    Melle, Federica
    Motta, Giovanna
    Tabanelli, Valentina
    Fiori, Stefano
    Vegliante, Maria Carmela
    Mazzara, Saveria
    Ciavarella, Sabino
    Derenzini, Enrico
    CELLS, 2021, 10 (03) : 1 - 15
  • [10] TNF-α Expression in Tumor Cells as a Novel Prognostic Marker for Diffuse Large B-cell Lymphoma, Not Otherwise Specified
    Nakayama, Shoko
    Yokote, Taiji
    Hirata, Yuji
    Akioka, Toshikazu
    Miyoshi, Takuji
    Hiraoka, Nobuya
    Iwaki, Kazuki
    Takayama, Ayami
    Nishiwaki, Uta
    Masuda, Yuki
    Nishimura, Yasuichiro
    Tsuji, Motomu
    Hanafusa, Toshiaki
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2014, 38 (02) : 228 - 234